94 related articles for article (PubMed ID: 18499717)
1. Systemic lupus erythematosus and Franklin's disease: when the somatic mutation mechanism makes a mistake.
García-Muñoz R; Panizo E; Rodriguez-Otero P; Mugueta-Uriaque MC; Rifon J; Llorente L; Panizo C
Rheumatology (Oxford); 2008 Jul; 47(7):1105-6. PubMed ID: 18499717
[No Abstract] [Full Text] [Related]
2. [Franklin's disease with heavy chain paraproteins].
Motta MC
Rev Bras Med; 1969 Sep; 26(9):553. PubMed ID: 5381895
[No Abstract] [Full Text] [Related]
3. Anesthetic management of a patient with Franklin's disease.
Barreiro JL; Cid M; Campaña O; Alvarez J
Reg Anesth; 1993; 18(2):136-7. PubMed ID: 8489982
[No Abstract] [Full Text] [Related]
4. [Paraproteinemias. Introduction to the study of plasmocytic reticulosis (lymphoproliferatives) monoclonal gammapathic-immunoglobulin dyscrasias (myeloma, macroglobulinemia, Franklin's disease)].
Farreras-Valentí P
Rev Clin Esp; 1968 Jul; 110(1):1-8. PubMed ID: 4186199
[No Abstract] [Full Text] [Related]
5. [A so-far unknown clinical and biochemical variant of paraproteinemia. "H-chain disease" or Franklin's disease].
Koch D
Dtsch Med Wochenschr; 1965 Nov; 90(48):2168-70. PubMed ID: 5844798
[No Abstract] [Full Text] [Related]
6. [Franklin's disease: remission after 3 months using chlorambucil].
Felman P; Bryon PA; Revol L; Creyssel R; Roda L
Nouv Presse Med; 1977 Nov; 6(39):3647. PubMed ID: 607182
[No Abstract] [Full Text] [Related]
7. A functional Ser(413)/Ser(413) PAI-2 polymorphism is associated with susceptibility and damage index score in systemic lupus erythematosus.
Palafox-Sánchez CA; Vázquez-Del Mercado M; Orozco-Barocio G; García-De la Torre I; Torres-Carrillo N; Torres-Carrillo NM; Illades-Aguiar B; Muñoz-Valle JF
Clin Appl Thromb Hemost; 2009; 15(2):233-8. PubMed ID: 18818228
[TBL] [Abstract][Full Text] [Related]
8. [Structure of immune globulin paraprotein and globulin in Franklin's syndrome].
Bogdanikowa B
Postepy Hig Med Dosw; 1966; 20(3):383-92. PubMed ID: 4161449
[No Abstract] [Full Text] [Related]
9. Clonal expansion of B-cells in human systemic lupus erythematosus: evidence from studies before and after therapeutic B-cell depletion.
Sfikakis PP; Karali V; Lilakos K; Georgiou G; Panayiotidis P
Clin Immunol; 2009 Jul; 132(1):19-31. PubMed ID: 19345151
[TBL] [Abstract][Full Text] [Related]
10. Mu-heavy chain and monoclonal IgG K paraproteinaemia in systemic lupus erythematosus.
Leach IH; Jenkins JS; Murray-Leslie CF; Powell RJ
Br J Rheumatol; 1987 Dec; 26(6):460-2. PubMed ID: 3120844
[TBL] [Abstract][Full Text] [Related]
11. DNASE I mutation and systemic lupus erythematosus in a Spanish population: comment on the article by Tew et al.
Balada E; Ordi-Ros J; Hernanz S; Villarreal J; Cortés F; Vilardell-Tarrés M; Labrador M
Arthritis Rheum; 2002 Jul; 46(7):1974-6; author reply 1976-7. PubMed ID: 12124889
[No Abstract] [Full Text] [Related]
12. [Familial lupus erythematosus].
Duk AV
Vestn Dermatol Venerol; 1968 Jul; 42(7):81-3. PubMed ID: 5738079
[No Abstract] [Full Text] [Related]
13. Antiphospholipid syndrome and systemic lupus erythematosus: are they separate entities or just clinical presentations on the same scale?
Shoenfeld Y; Meroni PL; Toubi E
Curr Opin Rheumatol; 2009 Sep; 21(5):495-500. PubMed ID: 19593144
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of soluble inducible costimulator ligand (ICOSL) in patients with systemic lupus erythematosus.
Her M; Kim D; Oh M; Jeong H; Choi I
Lupus; 2009 May; 18(6):501-7. PubMed ID: 19395451
[TBL] [Abstract][Full Text] [Related]
15. γ heavy chain disease presenting in a patient with systemic lupus erythematosus.
Wake LM; Ware AD
Blood; 2020 Jun; 135(23):2110. PubMed ID: 32497227
[No Abstract] [Full Text] [Related]
16. Analysis of C1q polymorphisms suggests association with systemic lupus erythematosus, serum C1q and CH50 levels and disease severity.
Martens HA; Zuurman MW; de Lange AH; Nolte IM; van der Steege G; Navis GJ; Kallenberg CG; Seelen MA; Bijl M
Ann Rheum Dis; 2009 May; 68(5):715-20. PubMed ID: 18504288
[TBL] [Abstract][Full Text] [Related]
17. Thrombotic events in systemic lupus erythematosus. Its association with acquired and inherited thrombophilic defects.
Vayá A; Santaolaria M; Micó L; Calvo J; Oropesa R; Villa P; Todoli J; Simó M; Corella D; Ricart JM
Clin Hemorheol Microcirc; 2008; 40(2):79-87. PubMed ID: 19029633
[TBL] [Abstract][Full Text] [Related]
18. Systemic lupus erythematosus and familial Mediterranean fever: a possible negative association between the two disease entities--report of four cases and review of the literature.
Lidar M; Zandman-Goddard G; Shinar Y; Zaks N; Livneh A; Langevitz P
Lupus; 2008 Jul; 17(7):663-9. PubMed ID: 18625639
[TBL] [Abstract][Full Text] [Related]
19. Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: delineation by expression of CD27, IgD, and CD95.
Jacobi AM; Reiter K; Mackay M; Aranow C; Hiepe F; Radbruch A; Hansen A; Burmester GR; Diamond B; Lipsky PE; Dörner T
Arthritis Rheum; 2008 Jun; 58(6):1762-73. PubMed ID: 18512812
[TBL] [Abstract][Full Text] [Related]
20. Somatic hypermutation of IGVH genes and aberrant somatic hypermutation in follicular lymphoma without BCL-2 gene rearrangement and expression.
Gagyi E; Balogh Z; Bödör C; Timár B; Reiniger L; Deák L; Csomor J; Csernus B; Szepesi A; Matolcsy A
Haematologica; 2008 Dec; 93(12):1822-8. PubMed ID: 18945749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
